BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26503433)

  • 1. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
    Zhang S; Jiang K; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
    Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
    Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
    Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
    Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
    Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
    Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.
    Tanabe K; Deguchi A; Higashi M; Usuki H; Suzuki Y; Uchimura Y; Kuriyama S; Ikenaka K
    Biochem Biophys Res Commun; 2008 Sep; 374(2):219-25. PubMed ID: 18619944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
    Zhang S; Shu H; Luo K; Kang X; Zhang Y; Lu H; Liu Y
    Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
    Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
    Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
    J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
    Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
    J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
    Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.